Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Director departure
|
ZS Pharma, Inc. (ZSPH)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/16/2016 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
12/29/2015 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
12/21/2015 |
4
| DEVON PARK BIOVENTURES LP (10% Owner) has filed a Form 4 on ZS Pharma, Inc.
Txns:
| Unknown transaction of 9,748 shares
@ $90, valued at
$877.3k
Unknown transaction of 2,576,724 shares
@ $90, valued at
$231.9M
|
|
12/21/2015 |
4
| RASMUSSEN HENRIK S MD (Chief Medical Officer) has filed a Form 4 on ZS Pharma, Inc.
Txns:
| Disposed/sold 3,000 shares
@ $90, valued at
$270k
Disposed/sold 77,991 options to buy
@ $1.0257, valued at
$80k
Disposed/sold 116,987 options to buy
@ $2.1284, valued at
$249k
Disposed/sold 97,489 options to buy
@ $2.1284, valued at
$207.5k
Disposed/sold 23,457 options to buy
@ $10.9242, valued at
$256.2k
Disposed/sold 32,090 options to buy
@ $10.9242, valued at
$350.6k
Disposed/sold 1,820 options to buy
@ $27.16, valued at
$49.4k
Disposed/sold 31,637 options to buy
@ $27.16, valued at
$859.3k
Disposed/sold 1,799 options to buy
@ $55.57, valued at
$100k
Disposed/sold 15,076 options to buy
@ $55.57, valued at
$837.8k
|
|
12/21/2015 |
4
| OSTRO MARC (Director) has filed a Form 4 on ZS Pharma, Inc.
Txns:
| Disposed/sold 1,000 shares
@ $90, valued at
$90k
Disposed/sold 12,000 options to buy
@ $32.56, valued at
$390.7k
Disposed/sold 4,000 options to buy
@ $55.57, valued at
$222.3k
|
|
12/21/2015 |
4
| Babler Martin (Director) has filed a Form 4 on ZS Pharma, Inc. |
12/21/2015 |
4
| NOHRA GUY P (Director) has filed a Form 4 on ZS Pharma, Inc. |
12/21/2015 |
4
| Farrow Jeffrey S (CFO) has filed a Form 4 on ZS Pharma, Inc. |
12/21/2015 |
4
| Popovits Kimberly J (Director) has filed a Form 4 on ZS Pharma, Inc.
Txns:
| Disposed/sold 1,000 shares
@ $90, valued at
$90k
Disposed/sold 12,000 options to buy
@ $39.01, valued at
$468.1k
Disposed/sold 4,000 options to buy
@ $55.57, valued at
$222.3k
|
|
12/21/2015 |
4
| Tomasi Adam (See Remarks) has filed a Form 4 on ZS Pharma, Inc.
Txns:
| Disposed/sold 12,599 shares
@ $90, valued at
$1.1M
Disposed/sold 155,983 options to buy
@ $2.1284, valued at
$332k
Disposed/sold 3,190 options to buy
@ $10.9242, valued at
$34.8k
Disposed/sold 17,279 options to buy
@ $10.9242, valued at
$188.8k
Disposed/sold 4,095 options to buy
@ $27.16, valued at
$111.2k
Disposed/sold 22,125 options to buy
@ $27.16, valued at
$600.9k
Disposed/sold 99 options to buy
@ $46, valued at
$4.6k
Disposed/sold 4,675 options to buy
@ $46, valued at
$215.1k
Disposed/sold 1,717 options to buy
@ $55.57, valued at
$95.4k
Disposed/sold 15,158 options to buy
@ $55.57, valued at
$842.3k
|
|
12/21/2015 |
4
| Smith Cynthia (Chief Commercial Officer) has filed a Form 4 on ZS Pharma, Inc.
Txns:
| Disposed/sold 12,598 shares
@ $90, valued at
$1.1M
Disposed/sold 185,230 options to buy
@ $2.1284, valued at
$394.2k
Disposed/sold 5,504 options to buy
@ $10.9242, valued at
$60.1k
Disposed/sold 20,520 options to buy
@ $10.9242, valued at
$224.2k
Disposed/sold 2,791 options to buy
@ $27.16, valued at
$75.8k
Disposed/sold 30,246 options to buy
@ $27.16, valued at
$821.5k
Disposed/sold 1,799 options to buy
@ $55.57, valued at
$100k
Disposed/sold 15,076 options to buy
@ $55.57, valued at
$837.8k
|
|
12/21/2015 |
4
| AKKARAJU SRINIVAS (Director) has filed a Form 4 on ZS Pharma, Inc.
Txns:
| Disposed/sold 1,000 shares
@ $90, valued at
$90k
Disposed/sold 12,000 options to buy
@ $32.56, valued at
$390.7k
Disposed/sold 4,000 options to buy
@ $55.57, valued at
$222.3k
|
|
12/21/2015 |
4
| Asbury Mark (Chief Legal Officer) has filed a Form 4 on ZS Pharma, Inc. |
12/21/2015 |
4
| Guillem Alvaro (President) has filed a Form 4 on ZS Pharma, Inc.
Txns:
| Disposed/sold 15,654 shares
@ $90, valued at
$1.4M
Unknown transaction of 186,923 shares
@ $90, valued at
$16.8M
Disposed/sold 37,046 options to buy
@ $1.0257, valued at
$38k
Disposed/sold 50,694 options to buy
@ $2.5644, valued at
$130k
Disposed/sold 185,230 options to buy
@ $2.1284, valued at
$394.2k
Disposed/sold 155,983 options to buy
@ $2.1284, valued at
$332k
Disposed/sold 47,219 options to buy
@ $10.9242, valued at
$515.8k
Disposed/sold 25,096 options to buy
@ $10.9242, valued at
$274.2k
Disposed/sold 951 options to buy
@ $27.16, valued at
$25.8k
Disposed/sold 32,086 options to buy
@ $27.16, valued at
$871.5k
Disposed/sold 1,799 options to buy
@ $55.57, valued at
$100k
|
|
12/21/2015 |
4
| KEYSER D JEFFREY (COO) has filed a Form 4 on ZS Pharma, Inc.
Txns:
| Disposed/sold 12,353 shares
@ $90, valued at
$1.1M
Unknown transaction of 216,169 shares
@ $90, valued at
$19.5M
Disposed/sold 35,096 options to buy
@ $1.0257, valued at
$36k
Disposed/sold 50,694 options to buy
@ $2.5644, valued at
$130k
Disposed/sold 175,481 options to buy
@ $2.1284, valued at
$373.5k
Disposed/sold 136,485 options to buy
@ $2.1284, valued at
$290.5k
Disposed/sold 41,788 options to buy
@ $10.9242, valued at
$456.5k
Disposed/sold 24,603 options to buy
@ $10.9242, valued at
$268.8k
Disposed/sold 31,887 options to buy
@ $27.16, valued at
$866.1k
Disposed/sold 1,150 options to buy
@ $27.16, valued at
$31.2k
Disposed/sold 1,799 options to buy
@ $55.57, valued at
$100k
|
|
12/21/2015 |
4
| WHITING JOHN M (Director) has filed a Form 4 on ZS Pharma, Inc.
Txns:
| Disposed/sold 1,000 shares
@ $90, valued at
$90k
Disposed/sold 12,000 options to buy
@ $32.56, valued at
$390.7k
Disposed/sold 4,000 options to buy
@ $55.57, valued at
$222.3k
|
|
12/21/2015 |
4
| Alexander Robert (CEO) has filed a Form 4 on ZS Pharma, Inc.
Txns:
| Disposed/sold 30,750 shares
@ $90, valued at
$2.8M
Disposed/sold 448,453 options to buy
@ $2.1284, valued at
$954.5k
Disposed/sold 39,566 options to buy
@ $5.616, valued at
$222.2k
Disposed/sold 132,473 options to buy
@ $5.616, valued at
$744k
Disposed/sold 2,864 options to buy
@ $27.16, valued at
$77.8k
Disposed/sold 74,748 options to buy
@ $27.16, valued at
$2M
Disposed/sold 1,799 options to buy
@ $55.57, valued at
$100k
Disposed/sold 73,201 options to buy
@ $55.57, valued at
$4.1M
|
|
12/17/2015 |
8-K
| Quarterly results |
12/11/2015 |
4
| KEYSER D JEFFREY (COO) has filed a Form 4 on ZS Pharma, Inc.
Txns:
| Exercised 9,154 options to buy
@ $10.9242, valued at
$100k
|
|
12/11/2015 |
4
| Guillem Alvaro (President) has filed a Form 4 on ZS Pharma, Inc.
Txns:
| Exercised 9,154 options to buy
@ $10.9242, valued at
$100k
|
|
12/10/2015 |
4
| Smith Cynthia (Chief Commercial Officer) has filed a Form 4 on ZS Pharma, Inc.
Txns:
| Exercised 9,155 options to buy
@ $10.9242, valued at
$100k
|
|
12/10/2015 |
4
| Alexander Robert (CEO) has filed a Form 4 on ZS Pharma, Inc.
Txns:
| Exercised 17,807 options to buy
@ $5.616, valued at
$100k
|
|
12/10/2015 |
4
| Tomasi Adam (See Remarks) has filed a Form 4 on ZS Pharma, Inc.
Txns:
| Exercised 9,156 options to buy
@ $10.9242, valued at
$100k
|
|
12/10/2015 |
4
| Asbury Mark (Chief Legal Officer) has filed a Form 4 on ZS Pharma, Inc. |
11/09/2015 |
10-Q
| Quarterly Report for the period ended September 30, 2015 |
11/06/2015 |
8-K
| Form 8-K - Current report |
11/06/2015 |
8-K
| Form 8-K - Current report |
09/10/2015 |
8-K
| Form 8-K - Current report |
08/24/2015 |
4
| Creech Todd A (Former Chief Financial Officer) has filed a Form 4 on ZS Pharma, Inc.
Txns:
| Sold 20,000 shares
@ $50.03, valued at
$1M
Sold 50,000 shares
@ $49.76, valued at
$2.5M
Exercised 20,000 options to buy
@ $2.13, valued at
$42.6k
Exercised 50,000 options to buy
@ $2.13, valued at
$106.5k
|
|
08/24/2015 |
4
| WHITING JOHN M (Director) has filed a Form 4 on ZS Pharma, Inc.
Txns:
| Granted 4,000 options to buy
@ $55.57, valued at
$222.3k
Granted 1,000 restricted stock units
@ $0 |
|
08/06/2015 |
8-K
| Form 8-K - Current report |
08/06/2015 |
10-Q
| Quarterly Report for the period ended June 30, 2015 |
07/29/2015 |
8-K
| Form 8-K - Current report |
06/29/2015 |
4
| AKKARAJU SRINIVAS (Director) has filed a Form 4 on ZS Pharma, Inc.
Txns:
| Granted 4,000 options to buy
@ $55.57, valued at
$222.3k
Granted 1,000 restricted stock units
@ $0 |
|
|
|
|